Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin's lymphoma that affects the lymphatic system. It is characterized by the uncontrolled growth of abnormal B-cells in the mantle zone of the lymph nodes, which is why it is called mantle cell lymphoma.
The cause of MCL is not known, but it is more common in men than in women and usually affects people over the age of 60. The symptoms of MCL include swollen lymph nodes, fatigue, weight loss, and fever.
Patients with MCL should work closely with their healthcare team to create a treatment plan that is customized to their individual needs. It is important to follow the treatment plan closely and to keep all follow-up appointments to monitor the progress of the disease.
In summary, mantle cell lymphoma is a rare form of non-Hodgkin's lymphoma that affects the lymphatic system. It is more common in men than in women and usually affects people over the age of 60. The symptoms of MCL include swollen lymph nodes, fatigue, weight loss, and fever. Treatment options for MCL include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapy. The prognosis for MCL varies depending on the stage of the disease at the time of diagnosis.